Past development, present status and future prospects of combined chemotherapy of human tuberculosis

Acocella, G. (1983) Past development, present status and future prospects of combined chemotherapy of human tuberculosis. Indian Journal of Tuberculosis, Supplement, 30 (3). pp. 29-31.

Full text available as:

PDF - Requires Adobe Acrobat Reader or other PDF viewer.
151 Kb


While search for an ideal drug continues, use of available drugs should be optimised. The object of multiple drug combinations is not merely to prevent the selection of resistant mutants but also to ensure bactericidal action in respect of various subgroups of the bacillary population of a lesion in respect of their metabolic and growth characteristics. Pharmacokinetic studies have shown that the drugs do not interfere with each other’s action and all the three oral bactericidal drugs can be administered in a single preparation, thus reducing the number of pills/ capsules to be swallowed by the patient and the possibility of the patient omitting one or the other drug inadvertently. SM, INH, RMP and PZA reach their peak concentration approximately 2 hours after administration, the peak being 20-30 meg/ml in the case of SM and PZA and 10-12 meg/ml for RMP and INH. There are, however, marked inter-individual and intra-individual variations in absorption and excretion of drugs and their effectiveness is related more to the height of the peak blood levels achieved than their half-life.

EPrint Type:Article
Uncontrolled Keywords:Combined Chemotherapy, Tuberculosis, Human, Pharmacokinetics, Streptomycin, INH, PZA, Pyrazinamide, Thioacetazone, Mycobacterium tuberculosis, Isoniazid, Rifampicin,
Subjects:Organic Chemicals > Hydrazines > Isoniazid
Heterocyclic Compounds > Heterocyclic Compounds with 4 or More Rings > Rifamycins
Pharmaceutical Preparations > Drug Combinations
Immunologic Diseases > Hypersensitivity > Drug Hypersensitivity
Chemical and Pharmacologic Phenomena > Biopharmaceutics
Investigative Techniques > Drug Administration Schedule
Heterocyclic Compounds > Heterocyclic Compounds, 1-Ring > Thiazoles
Bacteria > Gram-Positive Bacteria > Actinobacteria > Actinomycetales > Mycobacteriaceae > Mycobacterium > Mycobacterium tuberculosis
Respiratory Tract Diseases > Respiratory Tract Infections > Tuberculosis, Pulmonary
Biochemical Phenomena, Metabolism, and Nutrition > Metabolism
Carbohydrates and Hypoglycemic Agents > Carbohydrates > Glycosides > Aminoglycosides > Streptomycin
Heterocyclic Compounds > Heterocyclic Compounds, 1-Ring > Pyridines
Respiratory Tract Diseases > Lung Diseases > Tuberculosis, Pulmonary
-Journal Repositories > Indian Journal of Tuberculosis
ID Code:2674
Deposited By:Mrs Naina Pandita
Deposited On:05 March 2008

Archive Staff Only: edit this record